caffeine has been researched along with Cognitive Dysfunction in 25 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
Excerpt | Relevance | Reference |
---|---|---|
"The CAffeine, Postoperative Delirium And CHange In Outcomes after Surgery-2 (CAPACHINOS-2) Trial is a single-centre, placebo-controlled, randomised clinical trial that will be conducted at Michigan Medicine." | 9.69 | Caffeine, Postoperative Delirium And Change In Outcomes after Surgery (CAPACHINOS)-2: protocol for a randomised controlled trial. ( Inouye, SK; Jewell, E; Lee, U; Martinez, S; Mashour, GA; McKinney, A; Mentz, G; Ragheb, J; Runstadler, N; Schmitt, EM; Vanini, G; Vlisides, PE, 2023) |
"Epidemiologic studies have provided inconclusive evidence for a protective effect of caffeine consumption on risk of dementia and cognitive decline." | 9.05 | Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review. ( Chen, JQA; Groot, C; Ossenkoppele, R; Scheltens, P, 2020) |
"Ryanodine receptor agonist caffeine may improve cognitive dysfunction in mice after isoflurane anesthesia." | 8.31 | Activating ryanodine receptor improves isoflurane-induced cognitive dysfunction. ( Gu, X; Liu, B; Ma, Z; Qian, Y; Su, Y; Xia, T; Zhou, Q; Zhu, X, 2023) |
"Recent evidence indicates that caffeine may have a beneficial effect on cognitive decline and dementia." | 7.85 | Caffeine impact on working memory-related network activation patterns in early stages of cognitive decline. ( Giannakopoulos, P; Haller, S; Hofmeister, J; Montandon, ML; Moser, D; Rodriguez, C; Toma, S, 2017) |
" In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against late-life cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men." | 6.52 | Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. ( Barulli, MR; Bonfiglio, C; Guerra, V; Logroscino, G; Osella, A; Panza, F; Pilotto, A; Sabbà, C; Seripa, D; Solfrizzi, V, 2015) |
"Caffeine is a psychoactive compound used widely to enhance cognitive functions in human or animal studies." | 5.72 | Effect of intranasal administration of caffeine on mPFC ischemia‑induced cognitive impairment in BALB/c mice. ( Farajdokht, F; Farhoudi, M; Farokhi-Sisakht, F; Kahfi-Ghaneh, R; Mahmoudi, J; Sadigh-Eteghad, S, 2022) |
"The CAffeine, Postoperative Delirium And CHange In Outcomes after Surgery-2 (CAPACHINOS-2) Trial is a single-centre, placebo-controlled, randomised clinical trial that will be conducted at Michigan Medicine." | 5.69 | Caffeine, Postoperative Delirium And Change In Outcomes after Surgery (CAPACHINOS)-2: protocol for a randomised controlled trial. ( Inouye, SK; Jewell, E; Lee, U; Martinez, S; Mashour, GA; McKinney, A; Mentz, G; Ragheb, J; Runstadler, N; Schmitt, EM; Vanini, G; Vlisides, PE, 2023) |
"Epidemiologic studies have provided inconclusive evidence for a protective effect of caffeine consumption on risk of dementia and cognitive decline." | 5.05 | Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review. ( Chen, JQA; Groot, C; Ossenkoppele, R; Scheltens, P, 2020) |
"Ryanodine receptor agonist caffeine may improve cognitive dysfunction in mice after isoflurane anesthesia." | 4.31 | Activating ryanodine receptor improves isoflurane-induced cognitive dysfunction. ( Gu, X; Liu, B; Ma, Z; Qian, Y; Su, Y; Xia, T; Zhou, Q; Zhu, X, 2023) |
"Recent evidence indicates that caffeine may have a beneficial effect on cognitive decline and dementia." | 3.85 | Caffeine impact on working memory-related network activation patterns in early stages of cognitive decline. ( Giannakopoulos, P; Haller, S; Hofmeister, J; Montandon, ML; Moser, D; Rodriguez, C; Toma, S, 2017) |
"Beneficial effects of caffeine on memory processes have been observed in animal models relevant to neurodegenerative diseases and aging, although the underlying mechanisms remain unknown." | 3.79 | Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats. ( Ardais, AP; Botton, PH; Costa, MS; Elisabetsky, E; Fioreze, GT; Forte, T; Klaudat, B; Nunes, F; Porciúncula, LO; Sallaberry, C; Souza, DO, 2013) |
" In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against late-life cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men." | 2.52 | Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. ( Barulli, MR; Bonfiglio, C; Guerra, V; Logroscino, G; Osella, A; Panza, F; Pilotto, A; Sabbà, C; Seripa, D; Solfrizzi, V, 2015) |
" The RCS results suggested an approximately linear dose-response relationship between the aforementioned metabolites and cognitive performance." | 1.91 | Associations between urinary caffeine and caffeine metabolites and cognitive function in older adults. ( Cai, J; Cen, M; Chen, X; Fu, X; Li, H; Song, L; Wu, J; Yao, T, 2023) |
"Caffeine intake was not associated with cognitive decline." | 1.72 | Caffeine Consumption and Dementia: Are Lewy Bodies the Link? ( Bennett, DA; Cornelis, MC; Morris, MC; Schneider, JA; Weintraub, S, 2022) |
"Caffeine is a psychoactive compound used widely to enhance cognitive functions in human or animal studies." | 1.72 | Effect of intranasal administration of caffeine on mPFC ischemia‑induced cognitive impairment in BALB/c mice. ( Farajdokht, F; Farhoudi, M; Farokhi-Sisakht, F; Kahfi-Ghaneh, R; Mahmoudi, J; Sadigh-Eteghad, S, 2022) |
"Methylphenidate (MPH) is a psychostimulant widely misused to increase wakefulness by drivers and students." | 1.62 | Stimulants cocktail: Methylphenidate plus caffeine impairs memory and cognition and alters mitochondrial and oxidative status. ( Barcellos, LJG; de Alcantara Barcellos, HH; Fortuna, M; Freddo, N; Koakoski, G; Maffi, VC; Mozzato, MT; Pompermaier, A; Rossato-Grando, LG; Soares, SM; Varela, ACC, 2021) |
"Caffeine is a common stimulant widely existed in food and has stimulatory effects on the central nervous system, shift-work individuals often rely on caffeine to maintain attention and keep awake." | 1.62 | Caffeine-related effects on cognitive performance: Roles of apoptosis in rat hippocampus following sleep deprivation. ( Huang, P; Huang, X; Li, H; Wang, P; Xie, G, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 13 (52.00) | 24.3611 |
2020's | 12 (48.00) | 2.80 |
Authors | Studies |
---|---|
Xu, YX | 1 |
Wang, H | 1 |
Li, XK | 1 |
Dong, SN | 1 |
Liu, WW | 1 |
Gong, Q | 1 |
Wang, TD | 1 |
Tang, Y | 1 |
Zhu, J | 1 |
Li, J | 1 |
Zhang, HY | 1 |
Mao, F | 1 |
Cornelis, MC | 1 |
Bennett, DA | 1 |
Weintraub, S | 1 |
Schneider, JA | 1 |
Morris, MC | 1 |
Fu, X | 1 |
Li, H | 2 |
Chen, X | 1 |
Cai, J | 2 |
Yao, T | 1 |
Song, L | 1 |
Cen, M | 1 |
Wu, J | 1 |
Farokhi-Sisakht, F | 1 |
Farhoudi, M | 1 |
Mahmoudi, J | 1 |
Farajdokht, F | 1 |
Kahfi-Ghaneh, R | 1 |
Sadigh-Eteghad, S | 1 |
Vlisides, PE | 1 |
Ragheb, J | 1 |
McKinney, A | 1 |
Mentz, G | 1 |
Runstadler, N | 1 |
Martinez, S | 1 |
Jewell, E | 1 |
Lee, U | 1 |
Vanini, G | 1 |
Schmitt, EM | 1 |
Inouye, SK | 1 |
Mashour, GA | 1 |
Merighi, S | 1 |
Travagli, A | 1 |
Nigro, M | 1 |
Pasquini, S | 1 |
Cappello, M | 1 |
Contri, C | 1 |
Varani, K | 1 |
Vincenzi, F | 1 |
Borea, PA | 1 |
Gessi, S | 1 |
Liu, B | 1 |
Zhu, X | 1 |
Zhou, Q | 1 |
Su, Y | 1 |
Qian, Y | 1 |
Ma, Z | 1 |
Gu, X | 1 |
Xia, T | 1 |
Iranpour, S | 1 |
Saadati, HM | 1 |
Koohi, F | 1 |
Sabour, S | 1 |
Freddo, N | 1 |
Soares, SM | 1 |
Fortuna, M | 1 |
Pompermaier, A | 1 |
Varela, ACC | 1 |
Maffi, VC | 1 |
Mozzato, MT | 1 |
de Alcantara Barcellos, HH | 1 |
Koakoski, G | 1 |
Barcellos, LJG | 1 |
Rossato-Grando, LG | 1 |
Chen, JQA | 1 |
Scheltens, P | 1 |
Groot, C | 1 |
Ossenkoppele, R | 1 |
Xie, G | 1 |
Huang, X | 1 |
Wang, P | 1 |
Huang, P | 1 |
Alhowail, A | 1 |
Aldubayan, M | 1 |
Londzin, P | 1 |
Zamora, M | 1 |
Kąkol, B | 1 |
Taborek, A | 1 |
Folwarczna, J | 1 |
Lalanne, L | 1 |
Lutz, PE | 1 |
Paille, F | 1 |
Hussain, A | 1 |
Tabrez, ES | 1 |
Mavrych, V | 1 |
Bolgova, O | 1 |
Peela, JR | 1 |
Dominguez, LJ | 1 |
Barbagallo, M | 1 |
Haller, S | 3 |
Montandon, ML | 3 |
Rodriguez, C | 3 |
Herrmann, FR | 1 |
Giannakopoulos, P | 3 |
Cassol, G | 1 |
Godinho, DB | 1 |
de Zorzi, VN | 1 |
Farinha, JB | 1 |
Della-Pace, ID | 1 |
de Carvalho Gonçalves, M | 1 |
Oliveira, MS | 1 |
Furian, AF | 1 |
Fighera, MR | 1 |
Royes, LFF | 1 |
Moser, D | 2 |
Toma, S | 2 |
Hofmeister, J | 2 |
Sinanaj, I | 1 |
Lovblad, KO | 1 |
Panza, F | 2 |
Solfrizzi, V | 2 |
Barulli, MR | 1 |
Bonfiglio, C | 1 |
Guerra, V | 2 |
Osella, A | 2 |
Seripa, D | 2 |
Sabbà, C | 2 |
Pilotto, A | 2 |
Logroscino, G | 2 |
Imbimbo, BP | 1 |
D'Introno, A | 1 |
Galluzzo, L | 1 |
Gandin, C | 1 |
Misciagna, G | 1 |
Baldereschi, M | 1 |
Di Carlo, A | 1 |
Inzitari, D | 1 |
Scafato, E | 1 |
Batalha, VL | 1 |
Ferreira, DG | 1 |
Coelho, JE | 1 |
Valadas, JS | 1 |
Gomes, R | 1 |
Temido-Ferreira, M | 1 |
Shmidt, T | 1 |
Baqi, Y | 1 |
Buée, L | 1 |
Müller, CE | 1 |
Hamdane, M | 1 |
Outeiro, TF | 1 |
Bader, M | 1 |
Meijsing, SH | 1 |
Sadri-Vakili, G | 1 |
Blum, D | 1 |
Lopes, LV | 1 |
Cao, C | 1 |
Loewenstein, DA | 1 |
Lin, X | 1 |
Zhang, C | 1 |
Wang, L | 1 |
Duara, R | 1 |
Wu, Y | 1 |
Giannini, A | 1 |
Bai, G | 1 |
Greig, M | 1 |
Schofield, E | 1 |
Ashok, R | 1 |
Small, B | 1 |
Potter, H | 1 |
Arendash, GW | 1 |
Sallaberry, C | 1 |
Nunes, F | 1 |
Costa, MS | 1 |
Fioreze, GT | 1 |
Ardais, AP | 1 |
Botton, PH | 1 |
Klaudat, B | 1 |
Forte, T | 1 |
Souza, DO | 1 |
Elisabetsky, E | 1 |
Porciúncula, LO | 1 |
9 reviews available for caffeine and Cognitive Dysfunction
Article | Year |
---|---|
Caffeine for Prevention of Alzheimer's Disease: Is the A
Topics: Alzheimer Disease; Caffeine; Coffee; Cognitive Dysfunction; Humans; Neuroprotective Agents; Receptor | 2023 |
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review.
Topics: Caffeine; Coffee; Cognitive Dysfunction; Dementia; Humans; Protective Factors; Sex Factors; Tea | 2020 |
Mechanisms underlying cognitive impairment induced by prenatal caffeine exposure.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Cognitive Dysfunction; Female; Fetal Developme | 2020 |
Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies.
Topics: Alzheimer Disease; Animals; Caffeine; Cognition; Cognitive Dysfunction; Humans | 2021 |
Acute impact of caffeinated alcoholic beverages on cognition: A systematic review.
Topics: Alcoholic Beverages; Alcoholic Intoxication; Caffeine; Cognitive Dysfunction; Energy Drinks; Humans | 2017 |
Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease.
Topics: Alzheimer Disease; Caffeine; Central Nervous System Stimulants; Cognitive Dysfunction; Humans; Prote | 2018 |
Nutritional prevention of cognitive decline and dementia.
Topics: Antioxidants; Autophagy; Caffeine; Catechin; Central Nervous System Stimulants; Chocolate; Cognitive | 2018 |
Potential therapeutic implications of ergogenic compounds on pathophysiology induced by traumatic brain injury: A narrative review.
Topics: Animals; Arginine; Brain Injuries, Traumatic; Caffeine; Carnitine; Central Nervous System Stimulants | 2019 |
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.
Topics: Alzheimer Disease; Caffeine; Coffee; Cognition; Cognition Disorders; Cognitive Dysfunction; Dementia | 2015 |
2 trials available for caffeine and Cognitive Dysfunction
Article | Year |
---|---|
Caffeine, Postoperative Delirium And Change In Outcomes after Surgery (CAPACHINOS)-2: protocol for a randomised controlled trial.
Topics: Aged; Caffeine; Cognitive Dysfunction; Delirium; Emergence Delirium; Humans; Michigan; Randomized Co | 2023 |
Acute caffeine administration effect on brain activation patterns in mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Caffeine; Central Nervous System Stimulants; Cerebrovascular Circulation | 2014 |
14 other studies available for caffeine and Cognitive Dysfunction
Article | Year |
---|---|
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; | 2018 |
Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
Topics: Alzheimer Disease; Caffeine; Cognitive Dysfunction; Humans; Lewy Bodies; Neuropsychological Tests | 2022 |
Associations between urinary caffeine and caffeine metabolites and cognitive function in older adults.
Topics: Aged; Caffeine; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Humans; Male; Middle Aged | 2023 |
Effect of intranasal administration of caffeine on mPFC ischemia‑induced cognitive impairment in BALB/c mice.
Topics: Administration, Intranasal; Animals; Caffeine; Cognitive Dysfunction; Interleukin-10; Interleukin-6; | 2022 |
Activating ryanodine receptor improves isoflurane-induced cognitive dysfunction.
Topics: Anesthetics, Inhalation; Animals; Caffeine; Cognitive Dysfunction; Hippocampus; Isoflurane; Male; Mi | 2023 |
Association between caffeine intake and cognitive function in adults; effect modification by sex: Data from National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Topics: Age Factors; Aged; Aged, 80 and over; Caffeine; Central Nervous System Stimulants; Cognition; Cognit | 2020 |
Stimulants cocktail: Methylphenidate plus caffeine impairs memory and cognition and alters mitochondrial and oxidative status.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Cognition; Cognitive Dysfunction; Female; Male | 2021 |
Caffeine-related effects on cognitive performance: Roles of apoptosis in rat hippocampus following sleep deprivation.
Topics: Animals; Apoptosis; Arginine Vasopressin; Caffeine; Central Nervous System Stimulants; Cognition; Co | 2021 |
Impact of Coffee, Wine, and Chocolate Consumption on Cognitive Outcome and MRI Parameters in Old Age.
Topics: Aged; Aged, 80 and over; Brain; Caffeine; Cerebrovascular Circulation; Chocolate; Coffee; Cognition; | 2018 |
Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging.
Topics: Aged; Aged, 80 and over; Aging; Caffeine; Coffee; Cognitive Dysfunction; Depression; Feeding Behavio | 2015 |
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.
Topics: Aging; Animals; Caffeine; Cell Nucleus; Cognitive Dysfunction; Corticosterone; Humans; Hypothalamo-H | 2016 |
Caffeine impact on working memory-related network activation patterns in early stages of cognitive decline.
Topics: Aged; Caffeine; Case-Control Studies; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method | 2017 |
High Blood caffeine levels in MCI linked to lack of progression to dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caffeine; Case-Control Studies; Cognition; Cognitive Dys | 2012 |
Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats.
Topics: Aging; Animals; Avoidance Learning; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; C | 2013 |